Living with brucellosis often feels like battling a persistent, draining flu that refuses to go away. Also known as Mediterranean fever or Malta fever, this bacterial infection can cause recurring fevers, intense joint pain, fatigue, and night sweats. These symptoms can linger for weeks or even months, making it difficult to maintain work schedules or enjoy family time. The unpredictability of the symptoms, feeling better one day and exhausted the next is a common frustration for patients.

Treatment is essential to completely clear the bacteria from the body and prevent the infection from becoming chronic. Without effective intervention, brucellosis can lead to long-term complications affecting the heart, liver, or central nervous system. Because the bacteria that cause this condition hide inside the body’s cells, eliminating them requires a strategic and sustained medical approach. Treatment plans are tailored to the individual, taking into account which organs are affected and the patient’s age and general health (Centers for Disease Control and Prevention, 2024).

Overview of treatment options for Brucellosis

The primary goal of treatment is to cure the infection, relieve symptoms, and prevent the disease from returning (relapse). Unlike many minor bacterial infections that resolve with a short course of medicine, brucellosis requires a prolonged treatment duration, typically lasting six weeks or longer.

The standard approach involves antibiotic therapy. However, a key distinction in treating brucellosis is that using a single medication is rarely effective. Monotherapy (one drug) is associated with high rates of relapse. Therefore, the standard of care involves “combination therapy” using two or more antibiotics simultaneously to attack the bacteria from different angles. Surgery is rarely needed but may be considered if the infection causes complications like endocarditis (heart valve infection) or spinal abscesses.

Medications used for Brucellosis

Physicians rely on a few specific classes of antibiotics that are effective against Brucella bacteria. The most common first-line regimen involves combining a tetracycline antibiotic with a rifamycin.

Doxycycline is the most frequently prescribed tetracycline. It serves as the foundation of the treatment plan for most adults. It is almost always paired with a second drug to ensure the infection is fully eradicated.

The second medication is often rifampin (a rifamycin) or an aminoglycoside. The combination of doxycycline and rifampin is widely used because both pills can be taken orally, making it convenient for the long treatment course. Alternatively, clinical experience suggests that combining doxycycline with an injectable aminoglycoside, such as streptomycin or gentamicin, may offer slightly lower relapse rates, particularly in severe or complicated cases.

For specific populations who cannot take tetracyclines, such as pregnant women or young children, doctors may prescribe trimethoprim-sulfamethoxazole (a sulfonamide combination). This serves as an effective alternative to protect developing bones and teeth. Patients can typically expect fevers to break and energy levels to improve within a few days to a week of starting treatment, though completing the full course is non-negotiable (World Health Organization, 2020).

How these medications work

These antibiotics disrupt Brucella bacteria. Tetracyclines like doxycycline stop bacterial protein production by binding to ribosomes, preventing growth and repair.

Rifampin inhibits RNA synthesis, halting genetic replication. Aminoglycosides are bactericidal, killing bacteria by causing faulty proteins that destroy the cell wall. The combined use of these drugs creates a synergistic effect, stopping growth and killing remaining organisms, which significantly lowers the risk of relapse (National Institutes of Health, 2023).

Side effects and safety considerations

Managing side effects is crucial for successful, lengthy treatment. Doxycycline causes sun sensitivity, requiring sunscreen and protective clothing, and can cause stomach upset if taken without food. Rifampin harmlessly turns bodily fluids (urine, sweat, tears) bright orange/red.

Aminoglycosides (streptomycin/gentamicin) need close monitoring via regular blood tests for potential kidney or hearing damage. Certain antibiotics are avoided in pregnancy. Patients should seek immediate care for severe headaches, vision changes, or signs of allergy (hives, difficulty breathing) (Mayo Clinic, 2021).

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. Centers for Disease Control and Prevention. https://www.cdc.gov
  2. Mayo Clinic. https://www.mayoclinic.org
  3. National Institutes of Health. https://www.nih.gov
  4. World Health Organization. https://www.who.int

Medications for Brucellosis

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Brucellosis.

Found 2 Approved Drugs for Brucellosis

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (Ornithosis) due to Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis. Relapsing fever due to Borrelia recurrentis. Chancroid caused by Haemophilus ducreyi. Plague due to Yersinia pestis. Tularemia due to Francisella tularensis. Cholera caused by Vibrio cholerae. Campylobacter fetus infections caused by Campylobacter fetus. Brucellosis due to Brucella species (in conjunction with streptomycin). Bartonellosis due to Bartonella bacilliformis. Granuloma inguinale caused by Klebsiella granulomatis. Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli. Klebsiella aerogenes Shigella species. Acinetobacter species. Respiratory tract infections caused by Haemophilus influenzae. Respiratory tract and urinary tract infections caused by Klebsiella species. Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory tract infections caused by Streptococcus pneumoniae. Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections. Infections in women caused by Neisseria gonorrhoeae. Syphilis caused by Treponema pallidum subspecies pallidum. Yaws caused by Treponema pallidum subspecies pertenue. Listeriosis due to Listeria monocytogenes. Anthrax due to Bacillus anthraci s. Vincent’s infection caused by Fusobacterium fusiforme. Actinomycosis caused by Actinomyces israelii. Infections caused by Clostridium species. In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides. In severe acne, minocycline may be useful adjunctive therapy. Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. Oral minocycline is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum. To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Demeclocycline

Generic Name
Demeclocycline

Demeclocycline

Generic Name
Demeclocycline
Demeclocycline hydrochloride tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions below: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae; Respiratory tract infections caused by Mycoplasma pneumoniae Lymphogranuloma venereum due to Chlamydia trachomatis Psittacosis (Ornithosis) due to Chlamydia psittaci Trachoma due to Chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence Inclusion conjunctivitis caused by Chlamydia trachomatis Nongonococcal urethritis in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis Relapsing fever due to Borrelia recurrentis Chancroid caused by Haemophilus ducreyi Plague due to Yersinia pestis Tularemia due to Francisella tularensis Cholera caused by Vibrio cholerae Campylobacter fetus infections cause by Campylobacter fetus Brucellosis due to Brucella species (in conjunction with streptomycin); Bartonellosis due to Bartonella bacilliformis Granuloma inguinale caused by Calymmatobacterium granulomatis Demeclocycline hydrochloride tablets are indicated for treatment of infections by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli Enterobacter aerogenes Shigella species Acinetobacter species Respiratory tract infections caused by Haemophilus influenzae Respiratory tract and urinary tract infections caused by Klebsiella species Demeclocycline hydrochloride tablets are indicated for treatment of infections caused by the following gram-positive microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory infections caused by Streptococcus pneumoniae Skin and skin structure infections caused by Staphylococcus aureus. (Note: Tetracyclines, including demeclocycline, are not the drugs of choice in the treatment of any type of staphylococcal infection). When penicillin is contraindicated, tetracyclines, including demeclocycline hydrochloride, are alternative drugs in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae, and for the treatment of other uncomplicated gonococcal infections Infections in women caused by Neisseria gonorrhoeae Syphilis caused by Treponema pallidum subspecies pallidum Yaws caused by Treponema pallidum subspecies pertenue Listeriosis due to Listeria monocytogenes Anthrax due to Bacillus anthracis Vincent’s infection caused by Fusobacterium fusiforme Actinomycosis caused by Actinomyces israelii Clostridial diseases caused by Clostridium species In acute intestinal amebiasis, demeclocycline hydrochloride may be a useful adjunct to amebicides. In severe acne, demeclocycline hydrochloride may be a useful adjunctive therapy. To reduce the development of drug-resistant bacteria and maintain the effectiveness of demeclocycline hydrochloride tablets and other antibacterial drugs, demeclocycline hydrochloride tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances